CONMED Corporation Announces Third Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
CONMED (CNMD) PT Raised to $158 at Needham & Company
October 28, 2021 6:22 AM EDTNeedham & Company analyst Mike Matson raised the price target on CONMED (NASDAQ: CNMD) to $158.00 (from $150.00) while maintaining a Buy rating.
The analyst commented, "CNMD's 3Q21 revenue missed and EPS beat consensus. Management guided to the low-end of its prior revenue guidance range and... More
Conmed (CNMD) Tops Q3 EPS by 4c
October 27, 2021 4:24 PM EDTConmed (NASDAQ: CNMD) reported Q3 EPS of $0.80, $0.04 better than the analyst estimate of $0.76. Revenue for the quarter came in at $248.8 million versus the consensus estimate of $255.53 million.
GUIDANCE:
Conmed sees FY2021 EPS of $3.18-$3.23, versus the consensus of $3.19.
For earnings history and earnings-related data on Conmed (CNMD) click here.
... More